Japan Peripheral Nerve Stimulators Market Size, Share, and COVID-19 Impact Analysis, By Type (Implantable Stimulators and External Stimulators), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Providers), and Japan Peripheral Nerve Stimulators Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareJapan Peripheral Nerve Stimulators Market Size Insights Forecasts to 2035
- The Japan Peripheral Nerve Stimulators Market Size Was Estimated at USD 37.50 million in 2024
- The Market Size is Expected to Grow at a CAGR of Around 4.81 % from 2025 to 2035
- The Japan Peripheral Nerve Stimulators Market Size is Expected to Reach USD 62.9 million by 2035
Get more details on this report -
According to a Research Report Published by Spherical Insights & Consulting, the Japan Peripheral Nerve Stimulators Market Size is anticipated to reach USD 62.9 million by 2035, growing at a CAGR of 4.81 % from 2025 to 2035. The peripheral nerve stimulators market in Japan is driven by various factors, including rising prevalence of neurological disorders, government initiatives and healthcare reforms, rising adoption of minimally invasive procedures, and technological advancements.
Market Overview
A peripheral nerve stimulator (PNS) is a medical device that employs electrical pulses to interrupt or inhibit pain signals from peripheral nerves to the brain. The peripheral nerve stimulators (PNS) market includes the manufacturing, distribution, and sale of medical devices that send electrical impulses to peripheral nerves for therapeutic reasons. These devices can be implantable and external. These devices help to alleviate chronic pain, restore motor function, or support rehabilitation. Japan is witnessing a significant increase in neuropathic pain cases, affecting about 10 million people (8% of the population), which is driving the demand for peripheral nerve stimulators. Japan has one of the largest aging populations, and an aging population is more prone to chronic diseases, which creates more demand for effective pain management solutions is a major contributor to the market growth. The rising demand for personalized products is a key trend in this market. This trend presents an opportunity for manufacturers to develop personalized PNS devices that cater to individual patient needs.
Report Coverage
This research report categorizes the market for the Japan peripheral nerve stimulators market based on various segments and regions, and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan peripheral nerve stimulators market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan peripheral nerve stimulators market.
Japan Peripheral Nerve Stimulators Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 37.50 Million |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | 4.81 % |
2035 Value Projection: | USD 62.9 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 136 |
Tables, Charts & Figures: | 127 |
Segments covered: | By Type, By Distribution Channel and COVID-19 Impact Analysis |
Companies covered:: | Abbott Laboratories, Nevro Corp., Medtronic, Sawai Pharmaceutical Co. Ltd, Ito Physiotherapy & Rehabilitation Co., Ltd., Ono Pharmaceutical Co., Ltd., Toyobo Co., Ltd., and Other key vendors |
Pitfalls & Challenges: | COVID-19 Empact,Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The rising prevalence of neurological disorders, along with a rapidly aging population, drives the demand for effective pain management solutions, which drives the market growth. The market is expanding, and healthcare providers' trust is being increased by Japan's healthcare reforms and financial incentives for using technology like peripheral nerve stimulators. Additionally, the increasing use of minimally invasive operations in Japan is boosting demand for peripheral nerve stimulators for efficient pain control.
Restraining Factors
One of the notable restraints is the high cost of devices and procedures, which limits the accessibility for several patients. Additionally, strict regulations can lead to complexity and delay the entry of innovative products, which is hampering the market growth.
Market Segmentation
The Japan peripheral nerve stimulators market share is classified into type and distribution channel.
- The implantable stimulators segment held a dominant market share in 2024 and is expected to grow at a rapid CAGR during the forecast period.
The Japan peripheral nerve stimulators market is segmented by type into implantable stimulators and external stimulators. Among these, the implantable stimulators segment held a dominant market share in 2024 and is expected to grow at a rapid CAGR during the forecast period. This segmental growth is attributed to its high effectiveness in long-term chronic pain management. Additionally, technological advancements led to the development of more sophisticated and smaller devices.
- The hospital pharmacies segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The Japan peripheral nerve stimulators market is segmented by distribution channel into hospital pharmacies, retail pharmacies, and online providers. Among these, the hospital pharmacies segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the high volume of procedures performed in hospital settings. Additionally, the availability of trained healthcare professionals and specialized facilities further drives the segmental market growth.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan peripheral nerve stimulators market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Abbott Laboratories
- Nevro Corp.
- Medtronic
- Sawai Pharmaceutical Co. Ltd
- Ito Physiotherapy & Rehabilitation Co., Ltd.
- Ono Pharmaceutical Co., Ltd.
- Toyobo Co., Ltd.
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan peripheral nerve stimulators market based on the below-mentioned segments:
Japan Peripheral Nerve Stimulators Market, By Type
- Implantable Stimulators
- External Stimulators
Japan Peripheral Nerve Stimulators Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Providers
Need help to buy this report?